![]() |
市場調查報告書
商品編碼
2020217
腹腔鏡手術器械市場規模、佔有率、成長及全球產業分析:按類型、應用和地區分類的洞察,2026-2034年預測Laparoscopy Instruments Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球腹腔鏡手術器械市場規模為178.6億美元,預計2026年將成長至194億美元,到2034年將達到411.2億美元,預測期內年複合成長率為9.84%。2025年,北美市場佔據主導地位,市場佔有率達50.66%,主要得益於微創手術技術的高普及率以及主要企業的強大市場地位。
腹腔鏡手術,俗稱「微創手術」,是一種微創外科技術,使外科醫生能夠通過腹部和骨盆內的微小切口進行手術。腹腔鏡設備市場主要包括能量器材和內視鏡器械。能量器械,例如超音波和射頻器械,有助於有效切割組織;而內視鏡器械則用於組織操作、器官取出和固定等手術。
市場成長要素
外科醫生和患者對腹腔鏡手術日益成長的偏好是推動市場成長的主要因素之一。微創手術具有許多優勢,包括減少疤痕、縮短恢復時間、降低感染風險和減少住院時間。此外,膽結石、闌尾炎和疝氣等疾病在全球的發生率不斷上升,也進一步刺激了對腹腔鏡器械的需求。
2020年,新冠感染疾病導致手術延期,暫時降低了市場需求。然而,隨著手術數量的增加,市場在2021年和2022年復甦,預計這一穩定上升的趨勢將持續到2034年。
技術創新也在推動市場擴張。例如,手部輔助腹腔鏡手術(HALS)的引進簡化了切除術等複雜手術,其應用日益廣泛。根據韓國癌症協會的資料,腹腔鏡大腸直腸癌手術的比例從2013年的64.9%上升到2018年的78.5%,同期直腸癌手術的比例也從65.4%上升到81.6%。
市場區隔
依類型分類:能源設備細分市場規模最大,預計到2025年將佔市場佔有率的29.28%。其子類別包括產生器、血管封閉器和其他電外科器械。技術的不斷進步和對醫療設備採購日益成長的關注是推動該細分市場成長的主要因素。
依應用領域分類:一次性腹腔鏡器械因其安全性、便利性和低污染風險而佔據市場主導地位,預計到2025年將佔據 62.47%的市場佔有率。它們消除了消毒難題,並且越來越受到人們的青睞,超過了可重複使用的器械。
依應用領域分類,包括盲腸切除手術、膽囊切除術、疝氣修補術和減肥手術在內的普通外科手術佔比最大(到2025年達到47.75%),並且預計將持續成長。急性闌尾炎和膽結石病例的增加是推動這一趨勢的主要因素。例如,根據經合組織的資料,2020年法國所有盲腸切除手術中,腹腔鏡盲腸切除手術佔88.4%。
依最終用戶分類:預計到2026年,醫院和門診手術中心將佔據主導地位,佔市場佔有率的79.00%。這是因為病患數量龐大,人們對醫院普遍信任,進而推動了醫療設備的普及。
北美:2025年市場規模為90.5億美元,預計2026年將達98億美元。市場成長主要受手術量增加、微創手術需求成長以及Medtronic、BD和Ethicon等主要企業的強大市場地位所驅動。在美國,90%的膽囊切除術採用腹腔鏡手術,此技術已成為黃金標準。
亞太地區:該地區2025年市場規模達到30.3億美元,預計到2026年將成長至33.2億美元,主要促進因素是疾病患病率上升以及腹腔鏡手術作為傳統開放性手術的替代方案日益普及。在澳洲等國家,腹腔鏡腹股溝疝氣修補術的比例已從2010年的31.7%上升至2019年的46.8%。
歐洲和日本:腹腔鏡手術在結直腸外科、一般外科和婦科手術中的應用日益廣泛,加上手術器械技術的不斷創新,支撐著市場的穩定成長。
主要市場參與者
全球市場由ETHICON (Johnson & Johnson Services, Inc.)、Medtronic、Olympus Corporation、BD、CONMED、Stryker等主要企業主導。 ETHICON憑藉其強大的產品系列和廣泛的內視鏡手術器械銷售網路,佔據最大的市場佔有率。Olympus Corporation也透過POWERSEAL等產品持續鞏固其市場地位,POWERSEAL可用於開放性手術手術和腹腔鏡手術。
近期發展包括目的是加強腹腔鏡手術相關產品和擴大產品線的收購:
市場挑戰
儘管腹腔鏡手術發展迅速,但仍存在一些市場限制。這些因素包括腹腔鏡手術相關的併發症,例如側向熱擴散、手術煙霧風險以及套管針相關損傷。此外,在開發中國家,由於費用的考慮,患者往往更傾向於選擇開放性手術而非微創手術。
成長率:2026年至2034年的年複合成長率為9.84%。
The global laparoscopy instruments market was valued at USD 17.86 billion in 2025 and is projected to grow to USD 19.40 billion in 2026, reaching USD 41.12 billion by 2034, reflecting a CAGR of 9.84% over the forecast period. North America dominated the market in 2025 with a 50.66% share, driven by the high adoption of minimally invasive surgical techniques and strong presence of key players.
Laparoscopy, commonly known as keyhole surgery, is a minimally invasive surgical approach that allows surgeons to operate inside the abdomen and pelvis through small incisions. The market for laparoscopic devices primarily includes energy devices and endomechanical instruments. Energy devices, such as ultrasonic and high-frequency instruments, assist in cutting tissue efficiently, while endomechanical instruments are used for tissue manipulation, organ removal, and attachment procedures.
Market Growth Drivers
The increasing preference for laparoscopic procedures among both surgeons and patients is one of the major factors driving market growth. Minimally invasive procedures offer numerous benefits, including reduced scarring, shorter recovery times, lower risk of infection, and minimal hospital stays. Additionally, the rising global prevalence of conditions such as gallstones, appendicitis, and hernia has further boosted the demand for laparoscopic instruments.
The COVID-19 pandemic in 2020 caused a temporary decline in demand due to postponed elective surgeries. However, the market rebounded in 2021 and 2022 as surgical volumes increased, leading to a steady upward growth trajectory expected through 2034.
Technological innovations are also propelling market expansion. For instance, the introduction of Hand-assisted Laparoscopic Surgery (HALS) has simplified complex procedures like colectomy, increasing their adoption. Data from the Korean Cancer Association shows that laparoscopic colon cancer surgeries rose from 64.9% in 2013 to 78.5% in 2018, while rectal cancer procedures increased from 65.4% to 81.6% during the same period.
Market Segmentation
By Type: The energy devices segment is the largest, accounting for 29.28% of the market in 2025. Subcategories include generators, vessel sealers, and other electrosurgical tools. Continuous technological advancement and increased focus on capital equipment procurement are driving this segment.
By Usage: Disposable laparoscopic instruments dominate the market, with a 62.47% share in 2025, due to their safety, convenience, and low risk of contamination. They eliminate sterilization challenges and are increasingly preferred over reusable instruments.
By Application: General surgery, including appendectomy, cholecystectomy, hernia repair, and bariatric surgery, accounts for the highest share (47.75% in 2025) and is expected to grow steadily. Rising cases of acute appendicitis and gallstones contribute significantly to this trend. For example, OECD data shows laparoscopic appendectomies in France accounted for 88.4% of total appendectomy procedures in 2020.
By End-user: Hospitals and ambulatory surgical centers dominate with 79.00% market share in 2026, as large patient volumes and widespread trust in hospitals drive instrument adoption.
North America: Valued at USD 9.05 billion in 2025, the region is projected to reach USD 9.8 billion in 2026. Market growth is fueled by increasing surgical procedures, preference for minimally invasive techniques, and strong presence of major companies such as Medtronic, BD, and ETHICON. In the U.S., 90% of cholecystectomies are performed laparoscopically, establishing the method as the gold standard.
Asia Pacific: The region accounted for USD 3.03 billion in 2025, projected to grow to USD 3.32 billion in 2026, due to rising disease prevalence and increasing adoption of laparoscopic surgery over traditional open surgery. Countries like Australia have seen the laparoscopic repair of inguinal hernia rise from 31.7% in 2010 to 46.8% in 2019.
Europe and Japan: Increasing adoption of laparoscopic procedures for colorectal, general, and gynecological surgeries, coupled with strong technological innovation in instruments, supports steady market growth.
Key Market Players
The global market is consolidated with major companies including ETHICON (Johnson & Johnson Services, Inc.), Medtronic, Olympus Corporation, BD, CONMED, Stryker, and others. ETHICON holds the largest share due to its strong portfolio of endomechanical surgical instruments and extensive distribution network. Olympus Corporation has also strengthened its market presence with products like POWERSEAL devices, used in both open and laparoscopic surgeries.
Recent developments include acquisitions and product expansions aimed at enhancing laparoscopic offerings:
Market Challenges
Despite its growth, the market faces restraints, including complications associated with laparoscopic procedures such as lateral thermal spread, surgical smoke hazards, and trocar-related injuries. Additionally, in developing countries, cost considerations lead patients to prefer open surgeries over minimally invasive techniques.
Conclusion
The laparoscopy instruments market is poised for strong growth through 2034, driven by increasing demand for minimally invasive procedures, technological innovations, rising disease burden, and expanding healthcare infrastructure. With a projected market size of USD 41.12 billion by 2034, North America and Asia Pacific are expected to remain key contributors, while the ongoing adoption of energy devices and disposable instruments will continue to shape the market dynamics.
Growth Rate CAGR of 9.84% from 2026-2034
Segmentation By Type
By Usage
By Application
By End-user
By Region